Lymph Node Growth Rate in Testicular Germ Cell Tumours: Implications for Computed Tomography Surveillance Frequency

被引:2
作者
Mazrani, W. [2 ]
O'Malley, M. E. [1 ,2 ]
Chung, P. W. M. [1 ]
Warde, P. [1 ]
Vesprini, D. [3 ]
Panzarella, T. [4 ,5 ]
机构
[1] Univ Toronto, Princess Margaret Hosp, Dept Radiat Oncol, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Joint Dept Med Imaging, Toronto, ON M5S 1A1, Canada
[3] Univ Toronto, Sunnybrook Odette Canc Ctr, Dept Radiat Oncol, Toronto, ON M5S 1A1, Canada
[4] Princess Margaret Hosp, Canc Program, Dept Biostat, Toronto, ON M5G 2M9, Canada
[5] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada
关键词
Computed tomography; growth rate; lymph node; surveillance; testicular cancer; TESTIS CANCER; SEMINOMA; GUIDELINES; MANAGEMENT; RELAPSE;
D O I
10.1016/j.clon.2010.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Aim: To estimate the growth rate of lymph nodes in patients on surveillance for testicular cancer who developed recurrent disease. Materials and methods: During a 7-year period, 318 patients at our institution were managed by surveillance and 39 relapsed (12.3%). The computed tomography scans of 28 patients (median age 32 years; range 19-51 years) who met our inclusion criteria and who developed recurrent disease in the abdomen/pelvis were retrospectively reviewed. Thirteen patients had non-seminoma and 15 had seminoma. To estimate the lymph node growth rate, the slope of lymph node size over time was calculated. Results: The median length of time from orchiectomy to the recurrence computed tomography was 131 days (range 49-520) or about 4.4 months for non-seminoma patients and 373 days (range 129-675) or about 12.3 months for seminoma patients. The median size of the involved lymph node at final computed tomography for seminoma patients was 12 mm (range 9-31 mm) and for non-seminoma patients was 15 mm (range 10-56 mm). The median lymph node growth rate for patients with seminoma was 1.35 mm/month (range 0.62-4.56) and for patients with non-seminoma 2.99 mm/month (range 0.77-7.06); the difference in growth rates was statistically significant (P = 0.029). Conclusions: There is a statistically significant faster growth rate of lymph nodes in patients with recurrent non-seminoma compared with patients with seminoma. This finding supports a more frequent computed tomography schedule during the first 2 years of surveillance in non-seminoma patients compared with seminoma patients. (C) 2010 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:333 / 338
页数:6
相关论文
共 50 条
  • [31] Post-chemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection for Mixed Malignant Germ Cell Testicular Tumors
    Pickersgill, Nicholas A.
    Raval, Neel S.
    Kim, Eric H.
    Black, River G.
    Du, Kefu
    Figenshau, R. Sherburne
    CLINICAL GENITOURINARY CANCER, 2021, 19 (03) : 273.e1 - 273.e5
  • [32] Extraperitoneal laparoscopic retroperitoneal lymph node dissection after chemotherapy for nonseminomatous testicular germ-cell tumor: surgical and oncological outcomes
    Arai, Yoichi
    Kaiho, Yasuhiro
    Yamada, Shigeyuki
    Saito, Hideo
    Mitsuzuka, Koji
    Yamashita, Shinichi
    Namiki, Shunichi
    Nakagawa, Haruo
    Ishidoya, Shigeto
    Ito, Akihiro
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2012, 44 (05) : 1389 - 1395
  • [33] Intra-abdominal desmoid tumor following retroperitoneal lymph node dissection for testicular germ cell tumor
    Lawatsch, EJ
    Datta, MW
    Van Tuinen, P
    Sudakoff, GS
    Davis, NB
    Langenstroer, P
    INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (01) : 84 - 86
  • [34] A nomogram for predicting survival and retroperitoneal lymph node dissection treatment in patients with resected testicular germ cell tumors
    Wu, Yougen
    Meyers, Jeffrey P.
    Shi, Guowei
    Jin, Zhi
    Xia, Ju
    Gu, Yuting
    Qian, Qingqing
    Hong, Yang
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (03) : 508 - 517
  • [35] Adjunctive nephrectomy at post-chemotherapy retroperitoneal lymph node dissection for nonseminomatous germ cell testicular cancer
    Stephenson, Andrew J.
    Tal, Raanan
    Sheinfeld, Joel
    JOURNAL OF UROLOGY, 2006, 176 (05) : 1996 - 1999
  • [36] Late results of surveillance of clinical stage I nonseminoma germ cell testicular tumours: 17 years' experience in a national study in New Zealand
    Colls, BM
    Harvey, VJ
    Skelton, L
    Frampton, CMA
    Thompson, PI
    Bennett, M
    Perez, DJ
    Dady, PJ
    Forgeson, GV
    Kennedy, ICS
    BJU INTERNATIONAL, 1999, 83 (01) : 76 - 82
  • [37] Computed Tomography for Detecting Cervical Lymph Node Metastasis in Patients Who Have Papillary Thyroid Microcarcinoma with Tumor Characteristics Appropriate for Active Surveillance
    Lee, Dong-Hwa
    Kim, Yeo Koon
    Yu, Hyeong Won
    Choi, June Young
    Park, So Yeon
    Moon, Jae Hoon
    THYROID, 2019, 29 (11) : 1653 - 1659
  • [38] Treatment Outcomes for Men with Clinical Stage II Nonseminomatous Germ Cell Tumours Treated with Primary Retroperitoneal Lymph Node Dissection: A Systematic Review
    Neuenschwander, Anne
    Lonati, Chiara
    Antonelli, Luca
    Papachristofilou, Alexandros
    Cathomas, Richard
    Rothermundt, Christian
    Templeton, Arnoud J.
    Gulamhusein, Aziz
    Fischer, Stefanie
    Gillessen, Silke
    Hermanns, Thomas
    Lorch, Anja
    Mattei, Agostino
    Fankhauser, Christian D.
    EUROPEAN UROLOGY FOCUS, 2023, 9 (03): : 541 - 546
  • [39] Laparoscopic Retroperitoneal Lymph Node Dissection After Chemotherapy for Nonseminomatous Testicular Germ-Cell Tumor at a Single Center
    Shiota, Masaki
    Tanegashima, Tokiyoshi
    Tsukahara, Shigehiro
    Mutaguchi, Jun
    Goto, Shunsuke
    Kobayashi, Satoshi
    Matsumoto, Takashi
    Eto, Masatoshi
    ASIAN JOURNAL OF ENDOSCOPIC SURGERY, 2025, 18 (01)
  • [40] Value of Computed Tomography Scan for Detecting Lymph Node Metastasis in Early Esophageal Squamous Cell Carcinoma
    Zeng, Yunqing
    Liu, Yaping
    Li, Jinhou
    Feng, Bingcheng
    Lu, Jiaoyang
    ANNALS OF SURGICAL ONCOLOGY, 2025, 32 (03) : 1635 - 1650